Motif ID: Klf6_Patz1
Z-value: 1.212
Transcription factors associated with Klf6_Patz1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Klf6 | ENSMUSG00000000078.6 | Klf6 |
| Patz1 | ENSMUSG00000020453.11 | Patz1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Klf6 | mm10_v2_chr13_+_5861489_5861501 | 0.32 | 1.7e-02 | Click! |
| Patz1 | mm10_v2_chr11_+_3289168_3289281 | -0.32 | 1.9e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 9.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.9 | 5.6 | GO:0060596 | mammary placode formation(GO:0060596) |
| 1.8 | 5.3 | GO:0032430 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 1.5 | 4.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 1.5 | 4.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.4 | 4.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.3 | 2.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 1.3 | 7.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 1.2 | 6.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.2 | 4.9 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.2 | 10.9 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 1.2 | 4.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.1 | 3.4 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 1.1 | 1.1 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 1.1 | 5.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.1 | 33.5 | GO:0071625 | vocalization behavior(GO:0071625) |
| 1.1 | 4.3 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 1.1 | 3.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.0 | 3.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
| 1.0 | 6.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 1.0 | 2.9 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
| 1.0 | 9.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.9 | 2.8 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.9 | 7.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.9 | 2.8 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.9 | 0.9 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.9 | 6.3 | GO:0097324 | melanocyte migration(GO:0097324) |
| 0.9 | 4.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.9 | 4.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.8 | 9.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.8 | 3.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 0.8 | 2.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.8 | 5.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.8 | 2.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.8 | 4.1 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.8 | 3.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.8 | 2.4 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.8 | 3.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 0.8 | 3.1 | GO:0021586 | pons maturation(GO:0021586) |
| 0.8 | 0.8 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.8 | 2.3 | GO:0099548 | drug catabolic process(GO:0042737) exogenous drug catabolic process(GO:0042738) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by nitric oxide(GO:0099548) |
| 0.8 | 3.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.8 | 3.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.8 | 3.0 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 | 3.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.7 | 1.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.7 | 2.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 0.7 | 1.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 | 2.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.7 | 4.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 0.7 | 2.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.7 | 2.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.7 | 5.5 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
| 0.7 | 3.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.7 | 4.7 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.7 | 1.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.7 | 2.0 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.7 | 4.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.7 | 12.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.7 | 3.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.7 | 2.0 | GO:1904059 | positive regulation of sensory perception of pain(GO:1904058) regulation of locomotor rhythm(GO:1904059) |
| 0.6 | 3.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.6 | 12.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.6 | 2.5 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.6 | 2.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.6 | 2.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.6 | 1.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.6 | 4.3 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.6 | 4.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.6 | 3.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.6 | 4.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.6 | 1.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.6 | 3.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.6 | 3.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.6 | 1.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.5 | 1.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.5 | 2.2 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.5 | 7.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 | 5.9 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.5 | 1.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 0.5 | 2.1 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.5 | 2.6 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.5 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 | 3.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.5 | 2.1 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.5 | 1.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.5 | 5.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.5 | 1.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.5 | 1.5 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.5 | 2.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.5 | 1.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.5 | 1.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.5 | 2.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.5 | 13.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.5 | 1.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.5 | 1.4 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) regulation of connective tissue replacement(GO:1905203) |
| 0.5 | 1.4 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.5 | 1.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.5 | 6.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.5 | 1.4 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.5 | 0.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.5 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.5 | 1.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.4 | 1.8 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.4 | 2.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 2.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.4 | 1.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.4 | 1.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 1.3 | GO:0015866 | ADP transport(GO:0015866) |
| 0.4 | 1.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.4 | 1.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 | 0.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 0.4 | 1.7 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.4 | 1.3 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.4 | 0.4 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.4 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 | 1.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.4 | 0.4 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.4 | 4.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.4 | 2.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 | 2.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.4 | 3.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 | 2.4 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.4 | 1.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.4 | 1.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 6.3 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.4 | 2.0 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.4 | 3.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.4 | 2.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.4 | 2.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 2.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.4 | 1.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) chemoattraction of axon(GO:0061642) |
| 0.4 | 1.9 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.4 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.4 | 1.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.4 | 1.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.4 | 1.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 1.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.4 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 | 1.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.4 | 0.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 | 1.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 1.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.4 | 0.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.4 | 1.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
| 0.4 | 0.4 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 0.4 | 1.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.3 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 | 1.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.3 | 1.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.3 | 1.4 | GO:0050955 | thermoception(GO:0050955) |
| 0.3 | 0.3 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
| 0.3 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 0.3 | 0.7 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 | 2.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 | 3.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.3 | 5.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.3 | 1.0 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.3 | 1.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 | 1.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 | 2.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.3 | 2.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.3 | 1.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.3 | 2.6 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 1.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 | 0.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.3 | 1.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.3 | 2.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.3 | 0.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.3 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.3 | 0.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.3 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 0.9 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.3 | 0.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.3 | 1.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.3 | 6.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 | 1.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.3 | 1.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 | 2.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.3 | 1.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 | 1.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.3 | 0.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.3 | 1.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.3 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.3 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 | 4.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 | 2.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.3 | 1.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.3 | 0.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 | 2.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 1.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.3 | 1.7 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.3 | 1.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.3 | 1.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 3.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.3 | 0.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 | 5.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.3 | 1.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 | 1.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
| 0.3 | 1.1 | GO:0072185 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 6.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 1.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.3 | 0.8 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.3 | 2.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.3 | 0.5 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.3 | 0.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 0.3 | 2.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.3 | 1.9 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 | 0.5 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 0.3 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 | 1.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.3 | 0.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.3 | 1.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.3 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.3 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 3.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 | 1.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.3 | 0.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 | 4.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.3 | 6.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.3 | 1.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.3 | 1.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.3 | 0.5 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.3 | 2.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.3 | 1.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 2.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.3 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.3 | 1.0 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 6.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.2 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.2 | 3.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.2 | 1.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 | 0.5 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.2 | 0.7 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.2 | 1.0 | GO:0097393 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.2 | 0.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.2 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 5.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.2 | 0.7 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 | 2.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.2 | 0.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.2 | 0.9 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 1.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 4.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.2 | 3.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 1.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.2 | 1.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 2.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 | 1.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.2 | 0.5 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 | 0.2 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.2 | 1.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.2 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 1.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 1.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.2 | 4.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.2 | 1.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 0.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.2 | 0.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.2 | 0.6 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 | 0.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.2 | 0.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.2 | 1.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 1.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
| 0.2 | 1.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.2 | 2.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.2 | 0.2 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.2 | 1.2 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.2 | 0.4 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 | 1.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 | 2.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 0.4 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.2 | 0.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.2 | 0.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 | 0.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.2 | 3.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.2 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.2 | 0.6 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.2 | 0.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 | 0.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 | 1.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 1.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.2 | 0.6 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.2 | 0.8 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.2 | 1.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 | 0.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.2 | 0.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.2 | 1.5 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.2 | 1.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 0.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.2 | 1.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 3.6 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.2 | 0.4 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.2 | 0.6 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.2 | 0.6 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 | 1.7 | GO:0061072 | iris morphogenesis(GO:0061072) |
| 0.2 | 1.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 | 1.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 1.4 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.2 | 2.0 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 0.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.2 | 1.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 1.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 0.5 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.2 | 1.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 0.4 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
| 0.2 | 2.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 0.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 1.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.2 | 0.9 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.2 | 0.2 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.2 | 11.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.2 | 0.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.2 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.2 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 | 4.4 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 | 2.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 1.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.2 | 0.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 | 0.5 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 1.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 1.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 | 0.5 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.2 | 0.7 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.2 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
| 0.2 | 2.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 1.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 | 1.6 | GO:0021684 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 | 0.3 | GO:0061038 | uterus morphogenesis(GO:0061038) |
| 0.2 | 1.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 0.2 | 1.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 0.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 | 0.3 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.2 | 2.7 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 1.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.2 | 0.3 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 1.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 2.4 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.2 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.2 | 1.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 1.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.5 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.2 | 2.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.2 | 2.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.2 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.2 | 0.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 1.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.2 | 1.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 1.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 1.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.1 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.1 | 0.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 2.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) |
| 0.1 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 0.8 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.1 | 1.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 4.8 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.6 | GO:2000189 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.1 | 0.4 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 1.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
| 0.1 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 1.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 1.0 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.1 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 1.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 | 0.5 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 0.3 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.1 | 0.9 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.1 | 0.7 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.1 | 0.4 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.1 | 0.7 | GO:0036503 | ERAD pathway(GO:0036503) |
| 0.1 | 3.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 3.0 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.1 | 2.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.1 | 1.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.4 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.1 | 4.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 1.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.1 | 0.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.4 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 | 1.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 2.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.1 | 1.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.1 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.1 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 1.4 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 | 1.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 0.9 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 2.0 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 0.5 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
| 0.1 | 0.3 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.3 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.1 | 0.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 2.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.9 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 2.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.1 | 1.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.2 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 1.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 1.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
| 0.1 | 0.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.5 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 0.9 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 1.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
| 0.1 | 4.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.1 | 5.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.5 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 0.1 | 0.9 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.1 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 1.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.1 | 0.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.2 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 | 0.6 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.1 | 3.3 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.5 | GO:0071476 | cellular hypotonic response(GO:0071476) |
| 0.1 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 | 0.1 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
| 0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.1 | 1.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.1 | 0.3 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.1 | 0.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 1.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 1.0 | GO:0006497 | protein lipidation(GO:0006497) |
| 0.1 | 1.6 | GO:0098926 | postsynaptic signal transduction(GO:0098926) |
| 0.1 | 0.6 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 1.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.2 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.1 | 0.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
| 0.1 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 0.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.1 | 0.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 10.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 1.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.7 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 0.6 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 | 0.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.1 | 1.2 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.2 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 | 0.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 0.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 1.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 0.3 | GO:0045358 | germ-line stem cell population maintenance(GO:0030718) negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.1 | 0.2 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 1.6 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.1 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 1.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 0.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 3.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.6 | GO:0015800 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.8 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 3.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.1 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) |
| 0.1 | 0.1 | GO:0002842 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.1 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 | 0.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.1 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 1.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 0.2 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.1 | 1.0 | GO:0030810 | positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
| 0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 0.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 | 0.1 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.1 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 0.2 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 | 0.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.0 | 0.4 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
| 0.0 | 0.7 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.0 | 0.3 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.4 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.0 | 0.3 | GO:0097205 | renal filtration(GO:0097205) |
| 0.0 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.0 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.0 | 0.4 | GO:0006816 | calcium ion transport(GO:0006816) |
| 0.0 | 0.0 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.0 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 0.1 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.0 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
| 0.0 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 3.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.7 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.0 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 1.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.0 | 0.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.0 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 | 0.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.0 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.0 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.0 | 0.4 | GO:0051647 | nucleus localization(GO:0051647) |
| 0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.1 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
| 0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.4 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 | 1.5 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 | 0.1 | GO:0032604 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.0 | 0.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.3 | GO:0034312 | diol biosynthetic process(GO:0034312) |
| 0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.0 | 0.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 0.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.0 | 0.1 | GO:0018377 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.0 | 0.2 | GO:0007296 | cytoplasm organization(GO:0007028) vitellogenesis(GO:0007296) |
| 0.0 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 3.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 | 0.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.0 | 0.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
| 0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.0 | 0.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.0 | 0.6 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 1.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 0.0 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.0 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 1.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 0.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.0 | 0.6 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.0 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.0 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 | 2.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.0 | 0.0 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
| 0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.0 | 1.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
| 0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.2 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
| 0.0 | 0.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.0 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
| 0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
| 0.0 | 0.1 | GO:0090331 | regulation of platelet aggregation(GO:0090330) negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.8 | GO:0055085 | transmembrane transport(GO:0055085) |
| 0.0 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.0 | 0.0 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.0 | 0.3 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.0 | 0.2 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.0 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.0 | 0.0 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0098835 | presynaptic endosome(GO:0098830) presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
| 1.3 | 2.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.2 | 4.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 1.1 | 3.4 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 1.0 | 12.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.9 | 8.9 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.9 | 3.4 | GO:0090537 | CERF complex(GO:0090537) |
| 0.9 | 1.7 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
| 0.9 | 2.6 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.8 | 3.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 0.8 | 4.6 | GO:0008091 | spectrin(GO:0008091) |
| 0.7 | 2.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.7 | 12.6 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.7 | 2.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.7 | 3.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.7 | 2.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 2.0 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.7 | 5.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.6 | 2.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.6 | 11.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.5 | 5.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.5 | 2.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.5 | 8.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.5 | 13.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.5 | 5.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.4 | 1.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.4 | 3.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.4 | 3.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 3.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.4 | 1.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.4 | 1.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 0.4 | 2.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.4 | 23.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.4 | 6.7 | GO:0030673 | axolemma(GO:0030673) |
| 0.4 | 1.2 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
| 0.4 | 1.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.4 | 1.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.4 | 2.3 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.4 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.4 | 8.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.4 | 5.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.4 | 27.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.4 | 11.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.4 | 2.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.4 | 6.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 12.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.3 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 0.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.3 | 19.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.3 | 2.7 | GO:0005883 | neurofilament(GO:0005883) |
| 0.3 | 7.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.3 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.3 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.3 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.3 | 4.6 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.3 | 3.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 4.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 0.8 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 4.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 2.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.3 | 8.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.3 | 0.8 | GO:0000802 | transverse filament(GO:0000802) |
| 0.3 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.3 | 3.9 | GO:1902710 | GABA receptor complex(GO:1902710) |
| 0.3 | 5.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 0.3 | 3.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.3 | 9.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 2.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.3 | 1.5 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 3.9 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 1.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 1.0 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 0.2 | 7.4 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
| 0.2 | 1.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 1.9 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 4.0 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.2 | 1.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 4.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 47.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.2 | 2.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 0.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.2 | 4.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 4.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 1.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 2.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 1.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.2 | 5.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 2.5 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.2 | 0.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 9.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 9.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 1.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.2 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 1.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.2 | 15.0 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.2 | 1.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.2 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 1.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.2 | 0.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 1.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 4.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 0.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.2 | 1.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.2 | 2.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 1.3 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.1 | 0.4 | GO:0071920 | cleavage body(GO:0071920) |
| 0.1 | 1.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 0.6 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 5.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.1 | 10.5 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.1 | 5.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 3.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 1.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 3.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 0.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 2.5 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.1 | 7.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 2.6 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 1.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 1.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 11.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 6.7 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.1 | 0.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.1 | 1.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 2.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.1 | 2.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 3.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.1 | 4.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 2.6 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 3.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 6.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 1.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.6 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 2.6 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.2 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.1 | 2.0 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.2 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 0.1 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 2.4 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 2.0 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 10.9 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 4.1 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 4.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 2.2 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 1.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 0.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
| 0.0 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.0 | 3.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 1.6 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
| 0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 3.7 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.0 | 17.2 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 3.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.0 | 2.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 4.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 1.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.1 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.0 | 1.7 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.4 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
| 0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 2.9 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.0 | 1.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.1 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 3.5 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
| 0.0 | 0.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 30.6 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.6 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 2.8 | 8.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 2.5 | 10.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.7 | 5.0 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 1.4 | 4.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.4 | 9.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.2 | 4.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.2 | 9.3 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.1 | 4.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.1 | 4.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.1 | 3.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.0 | 6.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 1.0 | 5.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.9 | 2.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.9 | 3.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.8 | 3.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.8 | 5.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.8 | 2.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.8 | 2.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.8 | 4.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.8 | 0.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.8 | 12.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.8 | 10.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.7 | 5.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.7 | 3.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 0.7 | 3.9 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.7 | 2.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.6 | 1.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.6 | 2.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.6 | 11.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.6 | 5.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.6 | 1.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.6 | 3.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.6 | 2.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.5 | 2.7 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.5 | 2.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.5 | 2.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.5 | 3.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.5 | 2.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.5 | 2.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.5 | 1.0 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.5 | 4.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.5 | 11.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.5 | 4.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.5 | 5.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.5 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.5 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.5 | 6.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.5 | 3.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.4 | 1.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.4 | 1.3 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.4 | 1.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.4 | 3.5 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
| 0.4 | 1.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.4 | 1.7 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 0.4 | 1.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.4 | 7.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.4 | 2.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.4 | 4.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.4 | 2.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.4 | 1.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.4 | 3.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 1.2 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.4 | 1.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.4 | 1.6 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.4 | 2.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.4 | 6.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.4 | 2.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.4 | 6.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.4 | 1.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.4 | 2.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.4 | 1.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.4 | 4.1 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 2.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.4 | 7.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.4 | 1.5 | GO:0004096 | catalase activity(GO:0004096) |
| 0.4 | 1.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.4 | 1.5 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.4 | 1.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.4 | 14.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.4 | 3.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.4 | 2.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.4 | 1.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.4 | 3.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.3 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.3 | 1.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.3 | 1.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.3 | 1.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 2.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.3 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 1.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.3 | 2.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.3 | 1.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 0.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.3 | 3.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.3 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 1.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.3 | 2.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 0.9 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.3 | 1.2 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
| 0.3 | 2.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.3 | 12.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.3 | 4.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 1.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.3 | 0.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.3 | 0.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.3 | 2.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 1.1 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.3 | 0.8 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.3 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.3 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.3 | 7.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.3 | 1.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.2 | 4.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 1.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 9.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.2 | 7.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 0.9 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.2 | 2.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.2 | 0.7 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.2 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 1.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.2 | 2.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.2 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 2.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.2 | 0.7 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 0.2 | 0.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 0.6 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.2 | 0.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.2 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 0.8 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.2 | 8.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 2.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.2 | 1.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 31.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.2 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 0.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 4.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 0.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 1.2 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.2 | 4.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 4.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 3.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.2 | 1.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.2 | 0.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.2 | 8.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.2 | 0.4 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
| 0.2 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 0.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.2 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 2.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.2 | 10.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 1.4 | GO:0036122 | BMP binding(GO:0036122) |
| 0.2 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.2 | 3.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 0.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.2 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 0.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 1.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.2 | 5.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 4.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 1.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.2 | 0.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.2 | 1.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 2.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.2 | 7.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.2 | 1.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.2 | 3.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.2 | 1.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.2 | 22.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.3 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.1 | 2.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 2.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 2.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 1.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 6.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 3.6 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 2.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.1 | 10.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.1 | 0.5 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
| 0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 2.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.1 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 4.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 11.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.1 | 2.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.1 | 3.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 1.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.1 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.1 | 2.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 0.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 20.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 0.3 | GO:0098809 | nitrite reductase activity(GO:0098809) |
| 0.1 | 2.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.1 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 1.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 2.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 1.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.1 | 4.4 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 0.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.1 | 0.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.1 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 1.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.1 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.1 | 0.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.5 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
| 0.1 | 38.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.1 | 0.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 1.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 1.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 1.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 1.0 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 2.2 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.1 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.1 | 0.7 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
| 0.1 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.3 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 11.6 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
| 0.1 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.2 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.2 | GO:0036004 | GAF domain binding(GO:0036004) |
| 0.0 | 1.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.0 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.0 | 1.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.0 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
| 0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 1.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.2 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
| 0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 1.4 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.0 | 1.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.0 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.0 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.0 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 2.6 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.0 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.0 | 0.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 1.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 1.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 2.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.8 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.9 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.1 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.0 | 0.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.0 | 1.1 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.0 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 13.5 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 0.7 | 17.0 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.4 | 7.9 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 13.2 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.4 | 13.3 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.4 | 11.9 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 4.2 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.3 | 19.5 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.2 | 0.7 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 5.3 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 1.3 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 3.4 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.2 | 2.1 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 1.6 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 6.6 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.1 | 1.1 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 8.0 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.1 | 0.3 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 5.2 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 0.7 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.1 | 2.0 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.5 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 2.5 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.1 | 2.1 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.7 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 1.9 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 1.7 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 3.2 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 7.1 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.1 | 2.5 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.4 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 3.2 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.1 | 3.4 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.1 | 0.6 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 10.8 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.3 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 1.6 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 2.5 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.1 | 3.1 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 1.7 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.1 | 7.4 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.1 | 0.3 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.1 | 0.4 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 0.2 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 0.1 | 0.4 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.1 | 2.9 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.1 | 2.8 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 1.0 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 1.0 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.1 | 0.1 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.1 | 2.1 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 1.3 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 0.5 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.1 | 1.7 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.1 | 0.5 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.0 | 0.2 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 2.1 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.0 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.6 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.4 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.0 | 0.7 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.4 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.6 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.2 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.4 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.1 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.7 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.0 | 0.1 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.2 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.0 | 0.1 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 0.1 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.1 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 12.0 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.6 | 7.7 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.6 | 7.5 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.6 | 24.1 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.5 | 10.1 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 9.9 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.4 | 5.6 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.4 | 6.4 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 10.9 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 3.8 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 5.3 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 8.2 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.3 | 1.4 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.3 | 2.9 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.3 | 0.8 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 7.5 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.2 | 6.5 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 4.2 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 3.5 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 5.5 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 0.7 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 5.3 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 14.5 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 1.4 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 0.8 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 0.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 5.4 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.2 | 1.8 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.2 | 3.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 4.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 0.8 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 2.3 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 2.9 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 1.8 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 2.1 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 2.7 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 4.5 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 1.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 6.4 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.2 | 1.4 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 0.6 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 0.2 | 1.2 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.2 | 0.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 4.9 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.4 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.3 | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.1 | 2.9 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 4.6 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 2.9 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 1.9 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 0.9 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 2.8 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 0.9 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 4.5 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 2.2 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 0.9 | REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.1 | 1.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 3.1 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 5.4 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 1.0 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 8.7 | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.1 | 0.3 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.1 | 0.4 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 0.6 | REACTOME_NEURONAL_SYSTEM | Genes involved in Neuronal System |
| 0.1 | 2.5 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 0.6 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 2.7 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 1.7 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 5.7 | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.1 | 0.8 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 1.9 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 0.6 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 0.1 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 2.1 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 2.6 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 1.8 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 1.1 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 2.9 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.9 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 0.8 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 0.6 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 0.6 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 0.8 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 0.8 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 1.2 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 1.0 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 0.9 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.5 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 0.2 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 0.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 1.2 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 0.4 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 0.6 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 1.9 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.4 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 0.4 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 0.4 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 0.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.2 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 1.0 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.6 | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.0 | 0.7 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.7 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.4 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.5 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.0 | 0.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 0.4 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.8 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 1.9 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.1 | REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.5 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.1 | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.0 | 0.3 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
| 0.0 | 0.6 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.3 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.1 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.5 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.5 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.2 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.1 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.3 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.4 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.0 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 0.4 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.9 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.1 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
|
|
|